about
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of ...
Read More
21.34
-0.42
(-1.93%)
25.9M
XNYS Volume
XNYS 08 Aug, 2025 5:30 PM (EDT)
Estimates Miss
Kenvue's Q2 profit misses estimates by 10%, due to weak demand for allergy and sun care products
See details
High Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Kenvue Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..